Bordetella pertussis Infection of Primary Human Monocytes Alters HLA-DR Expression

Infection and Immunity

Volumn 72, Issue 3, 2004, Pages 1450-1462

  Shumilla, Jennifer A ^a,c   Lacaille, Vashti ^a,d   Hornell, Tara M C ^a   Huang, Jennifer ^a   Narasimhan, Supraja ^a   Relman, David A ^a,b   Mellins, Elizabeth D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Avigen Inc   (United States)

^d DiscoveRx Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD86 ANTIGEN; DIMER; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE HORMONE; PERTUSSIS TOXIN; VIRULENCE FACTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BORDETELLA PERTUSSIS; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOMODULATION; LETHALITY; MONOCYTE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESPIRATORY TRACT DISEASE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD86; BORDETELLA PERTUSSIS; CELL MEMBRANE; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; MEMBRANE GLYCOPROTEINS; MONOCYTES; PERTUSSIS TOXIN; RECOMBINANT PROTEINS;

EID: 1342344970     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.3.1450-1462.2004     Document Type: Article

References (72)

1. Accola, R. S. 1983. Human B cell variants immunoselected against a single 1a antigen subset have lost expression of several 1a antigen subsets. J. Exp. Med. 157:1053-1058.
2. Arunachalam, B., M. Pan, and P. Cresswell. 1998. Intracellular formation and cell surface expression of a complex of an intact lysosomal protein and MHC class II molecules. J. Immunol. 160:5797-5806.
3. Arunachalam, B., U. T. Phan, H. J. Geuze, and P. Cresswell. 2000. Enzymatic reduction of disulfide bonds in lysosomes: Characterization of a gamma-interferon-inducible lysosomal thiol reductase. Proc. Natl. Acad. Sci. USA 97:745-750.
4. Bakke, O., and T. W. Nordeng. 1999. Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting. Immunol. Rev. 172:171-187.
5. S6-kinase activation in IL-10 up-regulation in human monocytes by gp41 envelope protein of human immunodeficiency virus type 1. Pflueg. Arch. Eur. J. Physiol. 437:538-546.
6. Billing, R. J., M. Safani, and P. Peterson. 1976. Isolation and characterization of human B cell alloantigens. J. Immunol. 117:1589-1593.
7. Blanar, M. A., E. C. Boettger, and R. A. Flavell. 1988. Transcriptional activation of HLA-DRα by interferon γ requires a trans-acting protein. Proc. Natl. Acad. Sci. USA 85:4672-4676.
8. Boldrick, J., A. A. Alizadeh, M. Diehn, S. Dudoit, C. L. Liu, C. E. Belcher, D. Botstein, L. M. Staudt, P. O. Brown, and D. A. Relman. 2002. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. USA 99:972-977.
9. Boschwitz, J. S., J. W. Batanghari, H. Kedem, and D. A. Relman. 1997. Bordetella pertussis infection of human monocytes inhibits antigen-dependent CD4 T cell proliferation. J. Infect. Dis. 176:678-686.
10. Brachet, V., G. Raposo, S. Amigorena, and I. Mellman. 1997. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell Biol. 137:51-65.
11. Bromberg, K. G. Tannis, and P. Steiner. 1991. Detection of Bordetella pertussis associated with alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:4715-4719.
12. Byrne, A., and D. J. Reen. 2002. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J. Immunol. 168:1968-1977.
13. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782-787.
14. Cherry, J. D. 1997. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr. Infect. Dis. J. 16:S90-S96.
15. Cresswell, P. 1977. Human B cells alloantigens; separation from other membrane molecules by affinity chromatography. Eur. J. Immunol. 7:636-639.
16. De Magistris, M. T., M. Romano, S. Nuti, R. Rappuoli, and A. Tagliabue. 1988. Dissecting human T cell responses against Bordetella species. J. Exp. Med. 168:1351-1362.
17. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153-2165.
18. De Souza Leao, S., T. Lang, E. Prina, R. Hellio, and J.-C. Antione. 1995. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci. 108:3219-3231.
19. de Wall Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. teVelde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
20. Ding, L., P. S. Linsley, L.-Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
21. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924.
22. Finbloom, D. S., and K. D. Winestock. 1995. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1α and STAT3 complexes in human T cells and monocytes. J. Immunol. 155:1079-1090.
23. Fox, R. I., and H. I. Kang. 1993. Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation. Lupus 2:S9-S12.
24. Friedman, R. L., K. Nordensson, L. Wilson, E. T. Akporiaye, and D. E. Yocum. 1992. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect. Immun. 60:4578-4585.
25. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134-139.
26. Gross, M. K., D. C. Au, A. L. Smith, and D. R. Storm. 1992. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc. Natl. Acad. Sci. USA 89:4898-4902.
27. Guy, K., V. Van Heyningen, B. B. Cohen, D. L. Deane, and C. M. Steel. 1982. Differential expression and serologically distinct subpopulations of human 1a antigens detected with monoclonal antibodies to 1a alpha and beta chains. Eur. J. Immunol. 12:942-948.
28. Guzman, C. A., M. Rhode, M. Bock, and K. N. Timmis. 1994. Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect. Immun. 62:5528-5537.
29. Han, Y., Z.-H. L. Zou, and R. M. Ransohoff. 1999. TNF-α suppresses IFN-γ-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA. J. Immunol. 163:1435-1440.
30. Ishibashi, Y., D. A. Relman, and A. Nishikawa. 2001. Invasion of human respiratory epithelial cells by Bordetella pertussis: possible role for a filamentous hemagglutinin Arg-Gly-Asp sequence and α5β1 integrin. Microb. Pathog. 30:279-288.
31. Ishibashi, Y., S. Claus, and D. A. Relman. 1994. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180:1225-1233.
32. Kang, S., L. Liang, C. D. Parker, and J. F. Collawn. 1998. Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting. J. Biol. Chem. 273:20644-20652.
33. Kelley, V. E., W. Fiers, and T. B. Strom. 1984. Cloned human interferon-γ but not interferon-β or -α, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. J. Immunol. 132:240-245.
34. Kerr, J. R., and R. C. Matthews. 2000. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur. J. Clin. Microb. Infect. Dis. 19:77-88.
35. Koppelman, B., J. J. Neefjes, J. E. de Vries, and R. de Waal Malefyt. 1997. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861-871.
36. Kotenko, S. V., and S. Pestka. 2000. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19:2557-2565.
37. Lobo, P. I., M. Y. Chang, and E. Mellins. 1996. Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis. Immunology 88:625-629.
38. Masure, H. R. 1993. The adenylate cyclase toxin contributes to the survival of Bordetella pertussis within human macrophages. Microb. Pathog. 14:253-260.
39. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-231.
40. McGuirk, P., and K. H. G. Mills. 2000. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur. J. Immunol. 30:415-422.
41. Mellins, E., L. Smith, B. Arp, T. Cotner, E. Celis, and D. Pious. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343:71-74.
42. Mielcarek, N., E. H. Hornquist, B. R. Johansson, C. Locht, S. N. Abraham, and J. Holmgren. 2001. Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell. Microbiol. 3:181-188.
43. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bertman, J. J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551-554.
44. Mort, J. S., and D. J. Buttle. 1997. Cathepsin B. Int. J. Biochem. Cell Biol. 29:715-720.
45. Mouallem, M., Z. Farfel, and E. Hanski. 1990. Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion. Infect. Immun. 58:3759-3764.
46. Muhlethaler-Mottet, A., W. Di Berardino, L. A. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity 8:157-166.
47. Ogasawara, K., H. Kojima, H. Ikeda, N. Ishikawa, M. Kasahara, Y. Fukasawa, T. Natori, A. Wakisaka, Y. Kikuchi, and M. Aizawa. 1986. A study on class II antigens involved in the T cell proliferative responses to PPD using cross-reacting monoclonal antibodies in human and murine systems. Immunobiology 171:112-124.
48. Pearson, R. D., P. Symes, M. Conboy, A. A. Weiss, and E. L. Hewlett. 1987. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J. Immunol. 139:2749-2754.
49. + T-cell clones against Bordetella pertussis. Infect. Immun. 59:3768-3773.
50. Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P. Y. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J. Immunol. 160:233-240.
51. Polakova, K., and M. Karpatova. 1990. Study of monomorphic determinants on DR molecules of HLA class II antigens. Neoplasma 37:239-251.
52. Preston, N. W. 1986. Recognising whooping cough. Br. Med. J. 292:901-902.
53. 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375-1382.
54. Relman, D. A., M. Domenighini, E. Tuomanen, R. Rappuoli, and S. Falkow. 1989. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc. Natl. Acad. Sci. USA 86:2637-2641.
55. Ryan, M., G. Murphy, L. Gothefors, L. Nilsson, J. Storsaeter, and K. H. G. Mills. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175:1246-1250.
56. Sakatsume, M., K. Igarashi, K. D. Winestock, G. Garotta, A. C. Larner, and D. S. Finbloom. 1995. The Jak kinases differentially associate with the α and β (accessory factor) chains of the interferon γ receptor to form a functional receptor unit capable of activating STAT transcription factors. J. Biol. Chem. 270:17528-17534.
57. Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuommanen. 1991. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1143-1149.
58. Shen, X., F. Hong, V.-A. Nguyen, and B. Gao. 2000. IL-10 attenuates IFN-α-activated STAT1 in the liver: involvement of SOCS2 and SOCS3. FEBS Lett. 480:132-136.
59. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802-806.
60. Spriggs, M. K., R. J. Armitage, M. R. Comeau, L. Strockbine, T. Farrah, B. Macduff, D. Ulrich, M. R. Alderson, J. Mullberg, and J. I. Cohen. 1996. The extracellular domain of the Epstein-Barr virus BSLF2 protein binds the HLA-DR β chain and inhibits antigen presentation. J. Virol. 70:5557-5563.
61. Starr, R., T. A. Willson, E. M. Viney, L. J. L. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signaling. Nature 387:917-921.
62. Steel, C. M., V. Van Heyningen, K. Guy, B. B. Cohen, and D. L. Deane. 1982. Influence of monoclonal anti-Ia like antibodies on activation of human lymphocytes. Immunology 47:597-603.
63. Stumptner-Cuvelette, P., S. Morchoisne, M. Dugast, S. Le Gall, G. Raposo, O. Schwartz, and P. Benaroch. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. USA 98:12144-12149.
64. Tamir, A., and N. Isakov. 1994. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. J. Immunol. 152:3391-3399.
65. Thery, C., V. Brachet, A. Regnault, M. Rescigno, P. Ricciardi-Castagnoli, C. Bonnerot, and S. Amigorena. 1998. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the α- and β-chains. J. Immunol. 161:2106-2113.
66. Tuomanen, E., and A. Weiss. 1985. Characterization of two adhesions of Bordetella pertussis for human ciliated respiratory-epithelial cells. J. Infect. Dis. 152:118-125.
67. van't Wout, J., W. N. Burnette, V. L. Mar, E. Rozdzinski, S. D. Wright, and E. I. Tuomanen. 1992. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages. Infect. Immun. 60:3303-3308.
68. Walton, K. M., R. P. Rehfuss, J. C. Chrivia, J. E. Lochner, and R. H. Goodman. 1992. A dominant repressor of cyclic adenosine 3′,5′ -monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo. Mol. Endocrinol. 6:647-655.
69. Watanabe, M., T. Suzuki, M. Taniguchi, and N. Shinohara. 1983. Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologue of other mammalian species including humans. Transplantation 36:712-718.
70. Weiss, A. A., E. L. Hewlett, G. A. Myers, and S. Falkow. 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect. Immun. 42:33-41.
71. Wright, K. L., K.-C. Chin, M. Linhoff, C. Skinner, J. A. Brown, J. M. Boss, G. R. Stark, and J. P. Y. Ting. 1998. CIITA stimulation of transcription factor binding to major histocompatibility complex class Ii and associated promoters in vivo. Proc. Natl. Acad. Sci. USA 95:6267-6272.
72. Yue, F. Y., R. Dummer, R. Geertsen, G. Hofbauer, E. Laine, S. Manolio, and G. Gurg. 1997. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int. J. Cancer 71:630-637.